 |
PDBsum entry 1m5d
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
1m5d
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Membrane protein
|
 |
|
Title:
|
 |
X-ray structure of the glur2 ligand binding core (s1s2j-y702f) in complex with br-hibo at 1.73 a resolution
|
|
Structure:
|
 |
Glutamate receptor 2. Chain: a. Fragment: flop ligand binding core (s1s2j-y702f). Synonym: glur-2, glur-b, glur-k2, glutamate receptor ionotropic ampa 2. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Gene: glur-2. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
1.73Å
|
R-factor:
|
0.186
|
R-free:
|
0.215
|
|
|
Authors:
|
 |
A.Hogner,J.S.Kastrup,R.Jin,T.Liljefors,M.L.Mayer,J.Egebjerg, I.K.Larsen,E.Gouaux
|
Key ref:
|
 |
A.Hogner
et al.
(2002).
Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
J Mol Biol,
322,
93.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Jul-02
|
Release date:
|
18-Sep-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P19491
(GRIA2_RAT) -
Glutamate receptor 2 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
883 a.a.
258 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
322:93
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
|
|
A.Hogner,
J.S.Kastrup,
R.Jin,
T.Liljefors,
M.L.Mayer,
J.Egebjerg,
I.K.Larsen,
E.Gouaux.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Glutamate is the principal excitatory neurotransmitter within the mammalian CNS,
playing an important role in many different functions in the brain such as
learning and memory. In this study, a combination of molecular biology, X-ray
structure determinations, as well as electrophysiology and binding experiments,
has been used to increase our knowledge concerning the ionotropic glutamate
receptor GluR2 at the molecular level. Five high-resolution X-ray structures of
the ligand-binding domain of GluR2 (S1S2J) complexed with the three agonists
(S)-2-amino-3-[3-hydroxy-5-(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl]propionic
acid (2-Me-Tet-AMPA), (S)-2-amino-3-(3-carboxy-5-methylisoxazol-4-yl)propionic
acid (ACPA), and (S)-2-amino-3-(4-bromo-3-hydroxy-isoxazol-5-yl)propionic acid
(Br-HIBO), as well as of a mutant thereof (S1S2J-Y702F) in complex with ACPA and
Br-HIBO, have been determined. The structures reveal that AMPA agonists with an
isoxazole moiety adopt different binding modes in the receptor, dependent on the
substituents of the isoxazole. Br-HIBO displays selectivity among different AMPA
receptor subunits, and the design and structure determination of the S1S2J-Y702F
mutant in complex with Br-HIBO and ACPA have allowed us to explain the molecular
mechanism behind this selectivity and to identify key residues for ligand
recognition. The agonists induce the same degree of domain closure as AMPA,
except for Br-HIBO, which shows a slightly lower degree of domain closure. An
excellent correlation between domain closure and efficacy has been obtained from
electrophysiology experiments undertaken on non-desensitising GluR2i(Q)-L483Y
receptors expressed in oocytes, providing strong evidence that receptor
activation occurs as a result of domain closure. The structural results,
combined with the functional studies on the full-length receptor, form a
powerful platform for the design of new selective agonists.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Drawings showing the three agonists and their
interactions with the S1S2J protein. (a) 2-Me-Tet-AMPA, (b)
ACPA, and (c) Br-HIBO. The bonds of the protein are displayed in
yellow and the bound agonists bonds are in blue. Water molecules
are shown as red spheres, while remaining atoms are in standard
atomic colours (carbon is black, oxygen is red, nitrogen is
blue, and bromine is green). Broken lines indicate all potential
hydrogen bonds or ionic interactions within 3.3 Å.
Radiating spheres indicate hydrophobic contacts within 3.9
Å between carbon atoms in the agonist and neighbouring
residues. The only exception is in (c), where hydrophobic
contacts between the bromine atom and neighbouring residues are
displayed. The binding site of protomer A was employed for
(a) and (b), and the binding sites for protomers B and C have
similar structures. This Figure was prepared with the program
Ligplot.[55.] (d) F[o]−F[c] omit electron density map
contoured at 3.0σ for S1S2J:2-Me-Tet-AMPA, S1S2J:ACPA,
S1S2J:Br-HIBO, and S1S2J-Y702F:Br-HIBO was prepared by
BOBSCRIPT.[56.]
|
 |
Figure 4.
Figure 4. Surface electrostatic potential of part of the
binding site of 2-Me-Tet-AMPA in complex with S1S2J. Positive
potential is coloured in blue and negative potential in red, as
indicated by the coloured bar to the left. The labelled residues
form a well-defined partly hydrophobic and partly polar
cavity within the binding site of S1S2J. These residues are
within 3.9 Å from the 2-methyltetrazole ring, except from
residues Thr686 and Leu704, which are at a distance of 4.2
Å and 4.7 Å, respectively. The ligand 2-Me-Tet-AMPA
is shown in ball-and-stick representation, coloured as follows:
carbon is white, oxygen is red, and nitrogen is blue. The Figure
was prepared with the program Sybyl (Tripos Assoc. Inc.).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2002,
322,
93-0)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.S.Kristensen,
M.A.Jenkins,
T.G.Banke,
A.Schousboe,
Y.Makino,
R.C.Johnson,
R.Huganir,
and
S.F.Traynelis
(2011).
Mechanism of Ca(2+)/calmodulin-dependent kinase II regulation of AMPA receptor gating.
|
| |
Nat Neurosci,
14,
727-735.
|
 |
|
|
|
|
 |
A.Y.Lau,
and
B.Roux
(2011).
The hidden energetics of ligand binding and activation in a glutamate receptor.
|
| |
Nat Struct Mol Biol,
18,
283-287.
|
 |
|
|
|
|
 |
G.M.Alushin,
D.Jane,
and
M.L.Mayer
(2011).
Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists.
|
| |
Neuropharmacology,
60,
126-134.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Pøhlsgaard,
K.Frydenvang,
U.Madsen,
and
J.S.Kastrup
(2011).
Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.
|
| |
Neuropharmacology,
60,
135-150.
|
 |
|
|
|
|
 |
A.Birdsey-Benson,
A.Gill,
L.P.Henderson,
and
D.R.Madden
(2010).
Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors.
|
| |
J Neurosci,
30,
1463-1470.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.F.Petrik,
M.P.Strub,
and
J.C.Lee
(2010).
Energy transfer ligands of the GluR2 ligand binding core.
|
| |
Biochemistry,
49,
2051-2057.
|
 |
|
|
|
|
 |
A.H.Ahmed,
and
R.E.Oswald
(2010).
Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.
|
| |
J Med Chem,
53,
2197-2203.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Gonzalez,
M.Du,
K.Parameshwaran,
V.Suppiramaniam,
and
V.Jayaraman
(2010).
Role of dimer interface in activation and desensitization in AMPA receptors.
|
| |
Proc Natl Acad Sci U S A,
107,
9891-9896.
|
 |
|
|
|
|
 |
R.Edwards,
J.Madine,
L.Fielding,
and
D.A.Middleton
(2010).
Measurement of multiple torsional angles from one-dimensional solid-state NMR spectra: application to the conformational analysis of a ligand in its biological receptor site.
|
| |
Phys Chem Chem Phys,
12,
13999-14008.
|
 |
|
|
|
|
 |
A.H.Ahmed,
Q.Wang,
H.Sondermann,
and
R.E.Oswald
(2009).
Structure of the S1S2 glutamate binding domain of GLuR3.
|
| |
Proteins,
75,
628-637.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.B.Tikhonov,
and
L.G.Magazanik
(2009).
Origin and molecular evolution of ionotropic glutamate receptors.
|
| |
Neurosci Behav Physiol,
39,
763-773.
|
 |
|
|
|
|
 |
E.J.Bjerrum,
and
P.C.Biggin
(2008).
Rigid body essential X-ray crystallography: distinguishing the bend and twist of glutamate receptor ligand binding domains.
|
| |
Proteins,
72,
434-446.
|
 |
|
|
|
|
 |
L.A.Cruz,
E.Estébanez-Perpiñá,
S.Pfaff,
S.Borngraeber,
N.Bao,
J.Blethrow,
R.J.Fletterick,
and
P.M.England
(2008).
6-Azido-7-nitro-1,4-dihydroquinoxaline-2,3-dione (ANQX) forms an irreversible bond to the active site of the GluR2 AMPA receptor.
|
| |
J Med Chem,
51,
5856-5860.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.K.Fenwick,
and
R.E.Oswald
(2008).
NMR spectroscopy of the ligand-binding core of ionotropic glutamate receptor 2 bound to 5-substituted willardiine partial agonists.
|
| |
J Mol Biol,
378,
673-685.
|
 |
|
|
|
|
 |
T.Mamonova,
K.Speranskiy,
and
M.Kurnikova
(2008).
Interplay between structural rigidity and electrostatic interactions in the ligand binding domain of GluR2.
|
| |
Proteins,
73,
656-671.
|
 |
|
|
|
|
 |
T.Mamonova,
M.J.Yonkunas,
and
M.G.Kurnikova
(2008).
Energetics of the cleft closing transition and the role of electrostatic interactions in conformational rearrangements of the glutamate receptor ligand binding domain.
|
| |
Biochemistry,
47,
11077-11085.
|
 |
|
|
|
|
 |
B.H.Kaae,
K.Harpsøe,
J.S.Kastrup,
A.C.Sanz,
D.S.Pickering,
B.Metzler,
R.P.Clausen,
M.Gajhede,
P.Sauerberg,
T.Liljefors,
and
U.Madsen
(2007).
Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites.
|
| |
Chem Biol,
14,
1294-1303.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Catarzi,
V.Colotta,
and
F.Varano
(2007).
Competitive AMPA receptor antagonists.
|
| |
Med Res Rev,
27,
239-278.
|
 |
|
|
|
|
 |
A.S.Kristensen,
M.T.Geballe,
J.P.Snyder,
and
S.F.Traynelis
(2006).
Glutamate receptors: variation in structure-function coupling.
|
| |
Trends Pharmacol Sci,
27,
65-69.
|
 |
|
|
|
|
 |
G.Ramanoudjame,
M.Du,
K.A.Mankiewicz,
and
V.Jayaraman
(2006).
Allosteric mechanism in AMPA receptors: a FRET-based investigation of conformational changes.
|
| |
Proc Natl Acad Sci U S A,
103,
10473-10478.
|
 |
|
|
|
|
 |
M.C.Weston,
P.Schuck,
A.Ghosal,
C.Rosenmund,
and
M.L.Mayer
(2006).
Conformational restriction blocks glutamate receptor desensitization.
|
| |
Nat Struct Mol Biol,
13,
1120-1127.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.L.Mayer
(2006).
Glutamate receptors at atomic resolution.
|
| |
Nature,
440,
456-462.
|
 |
|
|
|
|
 |
P.E.Chen,
and
D.J.Wyllie
(2006).
Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors.
|
| |
Br J Pharmacol,
147,
839-853.
|
 |
|
|
|
|
 |
W.Zhang,
A.Robert,
S.B.Vogensen,
and
J.R.Howe
(2006).
The relationship between agonist potency and AMPA receptor kinetics.
|
| |
Biophys J,
91,
1336-1346.
|
 |
|
|
|
|
 |
A.Inanobe,
H.Furukawa,
and
E.Gouaux
(2005).
Mechanism of partial agonist action at the NR1 subunit of NMDA receptors.
|
| |
Neuron,
47,
71-84.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.B.Nielsen,
D.S.Pickering,
J.R.Greenwood,
L.Brehm,
M.Gajhede,
A.Schousboe,
and
J.S.Kastrup
(2005).
Exploring the GluR2 ligand-binding core in complex with the bicyclical AMPA analogue (S)-4-AHCP.
|
| |
FEBS J,
272,
1639-1648.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Frølund,
J.R.Greenwood,
M.M.Holm,
J.Egebjerg,
U.Madsen,
B.Nielsen,
H.Bräuner-Osborne,
T.B.Stensbøl,
and
P.Krogsgaard-Larsen
(2005).
Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology.
|
| |
Bioorg Med Chem,
13,
5391-5398.
|
 |
|
|
|
|
 |
D.R.Madden,
N.Armstrong,
D.Svergun,
J.Pérez,
and
P.Vachette
(2005).
Solution X-ray scattering evidence for agonist- and antagonist-induced modulation of cleft closure in a glutamate receptor ligand-binding domain.
|
| |
J Biol Chem,
280,
23637-23642.
|
 |
|
|
|
|
 |
H.Bräuner-Osborne,
L.Bunch,
N.Chopin,
F.Couty,
G.Evano,
A.A.Jensen,
M.Kusk,
B.Nielsen,
and
N.Rabasso
(2005).
Azetidinic amino acids: stereocontrolled synthesis and pharmacological characterization as ligands for glutamate receptors and transporters.
|
| |
Org Biomol Chem,
3,
3926-3936.
|
 |
|
|
|
|
 |
M.Du,
S.A.Reid,
and
V.Jayaraman
(2005).
Conformational changes in the ligand-binding domain of a functional ionotropic glutamate receptor.
|
| |
J Biol Chem,
280,
8633-8636.
|
 |
|
|
|
|
 |
M.H.Nanao,
T.Green,
Y.Stern-Bach,
S.F.Heinemann,
and
S.Choe
(2005).
Structure of the kainate receptor subunit GluR6 agonist-binding domain complexed with domoic acid.
|
| |
Proc Natl Acad Sci U S A,
102,
1708-1713.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.L.Mayer
(2005).
Glutamate receptor ion channels.
|
| |
Curr Opin Neurobiol,
15,
282-288.
|
 |
|
|
|
|
 |
M.M.Holm,
M.L.Lunn,
S.F.Traynelis,
J.S.Kastrup,
and
J.Egebjerg
(2005).
Structural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2.
|
| |
Proc Natl Acad Sci U S A,
102,
12053-12058.
|
 |
|
|
|
|
 |
M.M.Holm,
P.Naur,
B.Vestergaard,
M.T.Geballe,
M.Gajhede,
J.S.Kastrup,
S.F.Traynelis,
and
J.Egebjerg
(2005).
A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
|
| |
J Biol Chem,
280,
35469-35476.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Mamonova,
B.Hespenheide,
R.Straub,
M.F.Thorpe,
and
M.Kurnikova
(2005).
Protein flexibility using constraints from molecular dynamics simulations.
|
| |
Phys Biol,
2,
S137-S147.
|
 |
|
|
|
|
 |
K.Strømgaard,
and
I.Mellor
(2004).
AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins.
|
| |
Med Res Rev,
24,
589-620.
|
 |
|
|
|
|
 |
L.Brehm,
J.R.Greenwood,
F.A.Sløk,
M.M.Holm,
B.Nielsen,
U.Geneser,
T.B.Stensbøl,
H.Bräuner-Osborne,
M.Begtrup,
J.Egebjerg,
and
P.Krogsgaard-Larsen
(2004).
Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
|
| |
Chirality,
16,
452-466.
|
 |
|
|
|
|
 |
M.Kubo,
and
E.Ito
(2004).
Structural dynamics of an ionotropic glutamate receptor.
|
| |
Proteins,
56,
411-419.
|
 |
|
|
|
|
 |
M.L.Mayer,
and
N.Armstrong
(2004).
Structure and function of glutamate receptor ion channels.
|
| |
Annu Rev Physiol,
66,
161-181.
|
 |
|
|
|
|
 |
Q.Cheng,
and
V.Jayaraman
(2004).
Chemistry and conformation of the ligand-binding domain of GluR2 subtype of glutamate receptors.
|
| |
J Biol Chem,
279,
26346-26350.
|
 |
|
|
|
|
 |
A.Datta,
and
M.J.Stone
(2003).
Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold.
|
| |
Protein Sci,
12,
2482-2491.
|
 |
|
|
|
|
 |
T.N.Johansen,
J.R.Greenwood,
K.Frydenvang,
U.Madsen,
and
P.Krogsgaard-Larsen
(2003).
Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
|
| |
Chirality,
15,
167-179.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |